BioMedWire Stocks Archives - Page 4 of 79

ThursdayMar 19, 2026 10:00 am

Study Finds That Marijuana Legalization Lowers Crime Rates

David Eby, the Premier of British Columbia, has revealed that a wide range of American healthcare workers, including doctors, nurse practitioners and nurses have flocked to the Canadian province in search of employment and have secured jobs. Speaking at BC Children’s Hospital on Tuesday, the premier pointed out that the progressive social values, lifestyle and public healthcare system have been instrumental in attracting U.S.-trained medical workers to B.C. He added that the province respected science while making public health policies, has a high standard of living and respects reproductive rights. These, he said, have made the province an attractive place for healthcare workers from America. He highlighted that the…

TuesdayMar 17, 2026 10:00 am

Mirror-Image Amino Acid Shows Promise in Starving Cancer Cells

Most existing cancer treatments not only attack cancer cells but also adversely impact healthy body cells. The resultant damage to healthy tissues usually triggers side effects that often become severe, necessitating discontinuation of therapy or making quality of life worse. Scientists have been looking for better treatments that only impact malignant cells and leave healthy cells unaffected. A new preclinical study documents one such discovery leveraging the use of a mirror-image molecule. The study, conducted by a team based at Marburg University and University of Geneva, created a molecule similar to a naturally occurring amino acid referred to as cysteine. It contains sulfur within its composition. The researchers found that some cancers have a transporter on their…

FridayMar 13, 2026 10:00 am

Microbial Ecosystems Play a Big Role in the Efficacy of Cancer Immunotherapy

Significant strides have been made in leveraging checkpoint inhibitor therapy to combat a number of cancers over the recent years. However, not all malignancies respond to these therapies, and those that do often become resistant, or are discontinued due to adverse reactions within the immune system. Now, researchers have shown that gut microbiota are one of the key factors influencing the success of immunotherapy targeting PD-L1 and PD-1 gene expression. The study was published in the journal Cancer Biology and Medicine. The research team undertook a comprehensive review focused on seeking to understand how microbial ecosystems within the gut impact how patients respond to checkpoint inhibitors targeting PD-L1 and PD-1. They analyzed clinical trials, preclinical studies and available multi-omics data to ascertain how bacterial…

FridayMar 06, 2026 10:00 am

OSU Researchers Develop Nanomaterial That Eliminates Cancer Cells

Oregon State University researchers have engineered a new nanomaterial from iron that kills cancer cells inside tumors and leaves normal cells unaffected. This new nanomaterial works by triggering two chemical reactions inside tumors and the cancer cells die off as a result of these reactions. In a study that appeared in the journal Advanced Functional Materials, the scientists explain that the novel nanomaterial initiates two different chemical reactions that cause oxidative stress to kill cancer cells from the inside. Their work advances the field of chemodynamic therapy, also known as CDT. This field seeks to leverage the unique microenvironment inside tumors by altering the conditions that cancer cells thrive in in order to kill them off by denying the…

ThursdayMar 05, 2026 10:00 am

Researchers Say ICE Operations are Harming Public Health

The media has been awash with stories of intense sweeps by Immigration and Customs Enforcement (ICE) conducted in different cities, such as Minneapolis. While a lot of focus has been on the sometimes high-handed methods used during these operations, a team of researchers is drawing attention to the adverse public health effects of these ICE sweeps. University of Iowa’s Asst. Prof. Nicole Novak and Associate Professor William Lopez of the University of Michigan write that these operations have far-reaching effects on public health that take a while to fully come to light, and that it will take years to roll back those adverse effects. One of the effects they point out is that…

TuesdayMar 03, 2026 10:00 am

New Treatment Dramatically Improves Survival for Patients with Deadly Brain Tumors

Researchers at Keck Medicine, University of Southern California (USC) have discovered that combining immunotherapy with laser heat therapy could significantly extend the survival of individuals diagnosed with deadly brain cancers. Astrocytoma, which includes cancers like glioblastoma, grows aggressively and usually recurs after patients have undergone surgery to remove the tumors. This makes the cancer difficult to treat, and patients rarely survive for more than 5 months once diagnosed with high-grade astrocytoma. Immunotherapies, treatments that leverage the body’s immune system to fight cancer, work remarkably well in addressing cancers found in other body parts. However, these treatments exhibit dismal results when used against brain cancers. This is because the blood-brain…

FridayFeb 27, 2026 10:00 am

UCLA Researchers Develop Method to Fix Fuel Shortages in Cancer Immunotherapy

Many immunotherapies developed to combat cancer fail because the CAR-T cells become exhausted after being starved of oxygen in the tumor environment. A new preclinical study conducted by a team at UCLA has uncovered a method to deliver needed glucose to immune cells in a way that tumor cells cannot hijack. This offers hope of keeping anti-cancer fighter cells active and deadly to both solid and non-solid tumors. The study, whose findings appeared in Cell journal, documents how the researchers found a way to keep the oxygen supply of CAR-T cells intact in a way that cancer cells cannot steal and starve the immune cells. They…

ThursdayFeb 26, 2026 10:00 am

Medicare Advantage Insurers Record Slowing Growth in Member Enrollment

According to data released by the CMS last week, the expansion of people enrolled in Medicare Advantage (MA) plans has decelerated in 2026 to a degree that dwarfs what has been happening in recent years. The CMS data reveals that nearly 35.5 million individuals have so far enrolled for MA programs. This marks a paltry 3% growth of membership compared to last year which saw approximately 34.4 million individuals enroll for MA plans by this time of year. The 3% growth is a far cry from previous years that easily saw annual enrollment tick upwards by 10%. In recent years, the expansion of MA has continued to lose steam as many insurers withdraw from offering MA plans or scale down the number…

TuesdayFeb 24, 2026 10:00 am

American Science Suffers as Brain Drain Intensifies

The biomedical ecosystem in the U.S. is facing an unprecedented threat as younger researchers opt to work abroad amid the numerous challenges facing innovation within the United States. This brain drain particularly intensified starting last year when a number of policy changes left many with no option but to look for opportunities in other countries. For starters, thousands of grants have been slashed at the National Institutes of Health (NIH) and the National Science Foundation. Research projects at these institutions helped to absorb early career and entry-level scientists with new ideas that they studied using funding from the federal government. Without this vital entry point for young researchers, it is becoming extremely difficult for the country to maintain a…

FridayFeb 20, 2026 10:00 am

Cancer Stress Protein Enables Tumors to Evade the Immune System

A study published this week has found that when cancer cells are stressed, they produce a certain protein that helps the cancer to avoid detection by the immune system. This discovery opens an opportunity for developing therapies that target this particular protein in order to make immunotherapy more effective against cancer. The study, which was conducted by a large team led by a group at New York University Langone Health, focused on pancreatic and lung cancer tumors. They studied the ISR (Integrated Stress Response) of the tumors. Tumor cells are constantly stressed because they multiply so fast and often lack all the nutrients they need to support their survival and further…